MANILA, Philippines — The Philippines and Italy have sealed a new bilateral defense cooperation agreement after more than a year of review, the Department of Foreign Affairs said on Saturday night.

Inox Wind Q3 Results 2026: Renewable energy company Inox Wind announced its results for the quarter ended December 2025 (Q3FY26) on Friday, February 13. On the operational front, EBITDA was also up 39 ...

A new KPMG analysis reveals the gap between Boomers and Gen X is narrowing, while younger Australians are quietly getting richer For years, we’ve been told younger Aussies are falling behind – but new ...

Record Revenue of AED 12 billion, supported by strong conversion of a high-quality order book across all business segments. Net profit surged 89% YoY, driven by disciplined project selection, tighter ...

Courtesy: Food and Drug Administration director-general Paolo Teston (right) leads FDA compliance verification visits at retail establishments in Bonifacio Global City on Feb. 6, 2026. The visits are ...

SCOTTSDALE, Ariz., Jan. 30, 2026 /PRNewswire/ -- High-net-worth traders are increasingly recognizing that sustainable trading performance does not come from concentrating risk into a single account.

Total assets increased 16% yoy to AED 1.40 trillion RoTE at 19.2% remaining firmly above medium-term guidance The Board recommends a cash dividend of 80 fils per share for FY’25, subject to ...

With national elections set for February 1, Costa Rican citizens face a final push to secure their identity cards before heading to the polls. The Supreme Electoral Tribunal (TSE) has issued reminders ...

The justification offered—a concern about misuse and welfare dependency—is familiar and carefully vague. These phrases float around immigration policy like incense, creating the impression of ...

The raison d'être for a security partnership between the US and the Syrian Democratic Forces (SDF) has “largely expired”, US ambassador Tom Barrack said on Tuesday, as a sweeping compromise to end ...

ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary select operational results for the fiscal quarter and full year ending ...

The three-month period ending December 31, 2025, preliminary net product revenue of approximately $38.3 million, surpassing net product revenue of $31.8 million in the prior quarter, a 20% quarter ...